PATENT CLAIM ANALYSIS

Application Number: 15968110
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-08
Patent Classification: ["424", "450000"]

Abstract:
An object of the present invention is to provide a liposome composition containing a liposome having an excellent leakage rate of a nucleic acid analog anticancer agent, and a method for producing the same. According to the present invention, there are provided a liposome composition containing a liposome which (1) contains a nucleic acid analog anticancer agent and in which (2) a content ratio of a lysophospholipid contained in a lipid forming the liposome with respect to a total amount of phospholipids other than the lysophospholipid contained in the lipid forming the liposome is 0.01 mol % to 5 mol % and (3) a nucleic acid analog anticancer agent/lipid ratio is 2 mass % to 10 mass %, and a method for producing the same.

Claim (Index 10):
The method for producing a liposome composition according to  claim 6 , further comprising:\n a step (e) of adjusting an osmotic pressure of an inner aqueous phase of the liposome to be 2 to 8 times an osmotic pressure of an outer aqueous phase of the liposome.

Metadata:
- Claim Count in Document: 19.0
- Percentile: 93.0
- Lexical Diversity: 2.19355
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15336057', '15335640', '11371586', '12891568', '14440834']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7586888610071704
- 35 USC 102 Novelty (BERT): 0.5101660937101564
- Combined Prediction Score: 0.7338365842774689
- Mean Citation Score: 243.376524
- Max Citation Score: 288.22318
- Similarity Product: 211.5717129360652

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test